Related Experiment Video
Updated: Jun 5, 2025

Mouse Round Spermatid Injection
Published on: January 26, 2024
Eugenol Nanoparticles Ameliorate Doxorubicin-Induced Spermatogenic Dysfunction by Inhibiting the PINK1/Parkin and
Yang Fu1,2, Peipei Yuan1,2, Manyv Wang1
1Department of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China, Zhengzhou, 450046, People's Republic of China.
Purpose:
Doxorubicin (DOX) precipitates cell apoptosis in testicular tissues, and it is imperative to develop drugs to alleviate the spermatogenic disorders it causes. Eugenia caryophyllata Thunb is often used to treat male sexual disorders. Eugenol, a major component of Eugenia caryophyllata Thunb. has inadequate stability and low solubility, which limits its pharmacological effects. Eugenol nanoparticles (NPs) (ENPs) are expected to overcome these limitations. The protective effects of ENPs against DOX-induced reproductive toxicity were studied in mice.
Methods:
Eugenol was encapsulated in Methoxy-Poly(ethylene glycol)-Poly(lactide-co-glycolide) nanoparticles (mPEG-PLGA-NPs), and their role in ameliorating spermatogenic dysfunction was verified in vivo and in vitro.
Results:
We present a promising delivery system that encapsulates eugenol into mPEG-PLGA-NPs and forms them into nanocomposites. In vitro, ENPs significantly reduced doxorubicin-induced ROS and inflammatory factors in GC-1 cells and regulated the expression of the mitochondrial autophagy protein PINK1 and meiosis-related protein SCP3. In vivo, ENPs significantly increased sperm motility in mice, reduced apoptosis and oxidative stress in the testes, inhibited the testicular PINK1/Parkin and BNIP3/NIX signaling pathways, and enhanced the expression of factors associated with meiosis.
Conclusion:
Given their safety and efficacy, these ENPs have potential application prospects in mitigating doxorubicin-induced spermatogenic dysfunction.
Insights
Eugenol nanoparticles protect against doxorubicin-induced testicular damage by reducing oxidative stress and improving sperm motility. This study highlights their potential for mitigating reproductive toxicity.
Area of Science:
- Reproductive Toxicology
- Nanomedicine
- Pharmacology
Background:
- Doxorubicin (DOX) causes testicular apoptosis and spermatogenic disorders.
- Eugenol, derived from Eugenia caryophyllata, has limited bioavailability due to poor solubility and stability.
- Eugenol nanoparticles (ENPs) offer a potential solution to enhance eugenol's therapeutic effects.
Purpose of the Study:
- To investigate the protective effects of eugenol nanoparticles (ENPs) against doxorubicin-induced reproductive toxicity in mice.
- To evaluate the efficacy of ENPs in ameliorating DOX-induced spermatogenic dysfunction in vitro and in vivo.
Main Methods:
- Eugenol was encapsulated in Methoxy-Poly(ethylene glycol)-Poly(lactide-co-glycolide) nanoparticles (mPEG-PLGA-NPs) to create ENPs.
- In vitro studies assessed the impact of ENPs on doxorubicin-treated GC-1 cells, examining reactive oxygen species (ROS), inflammatory factors, and key protein expressions (PINK1, SCP3).
- In vivo studies in mice evaluated the effects of ENPs on sperm motility, testicular apoptosis, oxidative stress, and specific signaling pathways (PINK1/Parkin, BNIP3/NIX).
Main Results:
- ENPs significantly reduced doxorubicin-induced ROS and inflammation in GC-1 cells.
- ENPs normalized the expression of mitochondrial autophagy protein PINK1 and meiosis-related protein SCP3 in vitro.
- In vivo, ENPs improved sperm motility, decreased testicular apoptosis and oxidative stress, and modulated relevant signaling pathways, enhancing meiosis-associated factors.
Conclusions:
- ENPs demonstrate significant protective effects against doxorubicin-induced reproductive toxicity.
- The developed eugenol-loaded mPEG-PLGA-NPs show promise as a therapeutic strategy for mitigating DOX-induced spermatogenic dysfunction.
- ENPs represent a safe and effective delivery system with potential clinical applications in reproductive health.
More Related Videos
09:41Functional Assessment of Kinesin-7 CENP-E in Spermatocytes Using In Vivo Inhibition, Immunofluorescence and Flow Cytometry
Published on: December 28, 2021
09:09Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
Published on: June 23, 2020